Team:Calgary/Project/Achievements
From 2010.igem.org
(Difference between revisions)
Line 155: | Line 155: | ||
<ul> | <ul> | ||
- | |||
<li>More characterization was given to the Registry of Standard Parts for the cpxR promoter as well as for the degP promoter. Details can be found on our characterization page <a href="https://2010.igem.org/Team:Calgary/Parts/Characterization">here</a>. </li> | <li>More characterization was given to the Registry of Standard Parts for the cpxR promoter as well as for the degP promoter. Details can be found on our characterization page <a href="https://2010.igem.org/Team:Calgary/Parts/Characterization">here</a>. </li> | ||
</ul> | </ul> |
Revision as of 03:03, 28 October 2010
![University of Calgary iGEM Team 2010](http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Header4.png)
Achievements
Bronze Medal Requirements
![]() |
Register the team |
![]() |
Successfully complete and submit a project summary form |
![]() |
Create a Wiki which includes all the details of the project |
![]() |
Present a presentation and a poster at the iGEM Jamboree |
![]() Please see our Parts page here. |
Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Parts |
![]() Please see our Parts page here. |
Submit DNA for at least one new BioBrick Part or Device to the Registry of Parts |
Silver Medal Requirements
![]() |
Demonstrate that one of your parts works as expected |
- Using various methods of characterization, we confirmed that our CpxR reporter circuit was functional. In adition, our maltose binding protein (MalE) and mutant maltose binding protein (MalE31) were shown to be functionalClick here for more information.
- The CpxR reporter, MalE31, and MalE were shown to be functional through characterization. Click here for more information.
- More characterization was given to the Registry of Standard Parts for the cpxR promoter as well as for the degP promoter. Details can be found on our characterization page here.
- We tested out a part (nms6) for the University of Lethbridge. We assayed it for possible misfolding in the cytoplasm. Results can be found here.
- We attended an Alberta-wide conference where teams from the University of Calgary, the University of Lethbridge, and the University of Alberta did mock presentations, gave each other future directions, and gave possible troubleshooting methods.
- We filled out surveys for the University of Warsaw and the University of Edinburgh iGEM teams
- We chose to use current social media in the form of podcasts which covered different ethical issues pertaining to synthetic biology. These are posted here. In addition to this, an analysis of the social, ethical, and economical factors which our project dealt with was written and is posted here
![]() |
Characterize the operation of at least one new BioBrick Part or Device and enter this information on the Parts or Device page via the Registry of Parts |
Gold Medal Requirements
![]() |
Characterize or improve an existing BioBrick Part or Device and enter this information back on the Registry |
![]() |
Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system |
![]() |
Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation |